SCHEMBL1631941

SCHEMBL1631941

CC(C)CN1CC(Oc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK4 Q13043 10/20 0.46
JAK2 O60674 3/20 0.46
JAK1 P23458 3/20 0.46
TYK2 P29597 3/20 0.46
JAK3 P52333 3/20 0.46
TNIK Q9UKE5 1/20 0.44
CDK2 P24941 4/20 0.43
CCNA2 P20248 1/20 0.43
CCNA1 P78396 1/20 0.43
CDK1 P06493 3/20 0.42
CDK7 P50613 3/20 0.42
CDK9 P50750 3/20 0.42
CA2 P00918 2/20 0.42
CDK4 P11802 2/20 0.42
KDR P35968 2/20 0.42
CCNT1 O60563 2/20 0.42
CCNH P51946 2/20 0.42
CCND1 P24385 1/20 0.42
CCNB1 P14635 2/20 0.42
CCNE1 P24864 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632315 0.92 JAK2 (0.52) STK4JAK2JAK1TYK2JAK3
SCHEMBL1634003 0.90 JAK2 (0.48) STK4JAK2JAK1TYK2JAK3
SCHEMBL1633222 0.88 STK4 (0.48) STK4JAK2JAK1TYK2JAK3
SCHEMBL1632811 0.83 JAK2 (0.54) STK4JAK2JAK1TYK2JAK3
SCHEMBL1631022 0.83 JAK2 (0.54) STK4JAK2JAK1TYK2JAK3
SCHEMBL1633557 0.83 JAK2 (0.52) STK4JAK2JAK1TYK2JAK3
SCHEMBL1633462 0.83 JAK2 (0.55) STK4JAK2JAK1TYK2JAK3
SCHEMBL1632506 0.83 JAK2 (0.55) STK4JAK2JAK1TYK2JAK3
SCHEMBL1632504 0.83 JAK2 (0.55) STK4JAK2JAK1TYK2JAK3
SCHEMBL1634743 0.82 TNIK (0.55) STK4JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed